Psychiatry AtlasMedication guide · United States

Antipsychotic medicine

Ziprasidone (Geodon)

Generic name
ziprasidone (oral hydrochloride monohydrate; injectable mesylate trihydrate)
Brand names
Geodon
Medication class
Antipsychotic medicine
Forms covered
Geodon oral capsules; Geodon short-acting intramuscular injection

Article updated: 2026-10-24 · Sources last checked: 2026-11-05

Medication Safety Alerts

FDA Boxed Warning

Geodon oral capsules; Geodon short-acting intramuscular injection.

Ziprasidone increases the risk of death in older adults with dementia-related psychosis. Geodon is not approved for that use.

Ziprasidone (Geodon) treats schizophrenia and specified bipolar I conditions in adults. Its short-acting injection has a separate use for acute agitation associated with schizophrenia.

What to expect: Oral treatment may take a few weeks or longer for its fuller benefit.

Warning signs · Medicine forms
Sources last checked:
2026-11-05

What is this medicine used for?

FDA-approved uses

  • Schizophrenia — Adults. Oral treatment; pediatric safety and effectiveness have not been established.Geodon oral capsules.
  • Acute manic or mixed episodes associated with bipolar I disorder — Adults. Acute treatment as a single medication.Geodon oral capsules.
  • Maintenance treatment of bipolar I disorder — Adults. Only as an adjunct to lithium or valproate in this approval.Geodon oral capsules.
  • Acute agitation associated with schizophrenia — Adults. Short-acting IM treatment, not long-acting maintenance or IV use.Geodon short-acting intramuscular injection.

What should I expect?

Oral treatment may take a few weeks or longer for its fuller benefit. Changes in troubling thoughts, mood episodes and functioning should be reviewed over time.

The short-acting injection serves an immediate clinical need and is not a maintenance injection lasting weeks. Report severe restlessness, fainting or troublesome sedation promptly rather than waiting for a routine visit.

How do I take it safely?

Take oral capsules with food and swallow whole. Follow the prescribed schedule; do not open, crush or chew them. The short-acting injection is given by a professional into muscle, never into a vein.

Have every medicine checked for heart-rhythm and serotonin effects. Known QT prolongation, a recent heart attack, uncompensated heart failure and certain combinations rule out use. Report fainting or palpitations urgently.

MAO inhibitors must not be combined: wait at least 14 days after a psychiatric MAOI before ziprasidone and at least three days after ziprasidone before that MAOI. Linezolid and intravenous methylene blue need specific clinician management.

Monitor weight, blood pressure, glucose, blood fats and unusual movements. Depending on risk, the clinician may check an ECG, potassium, magnesium or blood-cell counts. Tell them about seizures, swallowing problems, liver or kidney disease and dehydration.

Avoid alcohol and unreviewed sedatives. Do not drive while impaired, and take care with overheating and standing up quickly.

Plan stopping or switching with the prescriber. For a missed oral dose, take it when remembered unless the next is near, then skip; never double. Injection scheduling belongs with the treating team.

Pediatric effectiveness is not established. Discuss pregnancy and breastfeeding: late-pregnancy antipsychotic exposure can cause newborn movement, feeding or breathing problems. Older adults with dementia-related psychosis face the boxed mortality risk.

What side effects should I know about?

  • Sleepiness, dizziness, nausea, vomiting or weakness.
  • Akathisia and other movement effects; injection-related headache may occur.

Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.

Which warning signs need help?

  • FDA boxed warning: older adults with dementia-related psychosis treated with antipsychotics have an increased risk of death. Geodon is not approved for dementia-related psychosis or its associated behavioral problems.
  • Fainting, palpitations or unexplained severe dizziness can signal a dangerous heart rhythm; seek urgent assessment.
  • High fever with severe muscle stiffness, confusion or unstable pulse can be neuroleptic malignant syndrome; get emergency care.
  • Report new uncontrollable movements promptly because they can persist. Severe restlessness, falls, fever with infection symptoms, or swallowing difficulty also needs medical advice.
  • Marked thirst, frequent urination, severe weakness or confusion may signal high blood sugar. Seek prompt assessment; severe illness needs urgent care.
  • Get urgent medical care for fever with confusion or agitation, heavy sweating, diarrhea and stiff or twitching muscles. This combination may be serotonin syndrome, a potentially life-threatening reaction.
  • Rash with fever, blisters, swelling or mouth sores needs urgent care. A prolonged painful erection also needs urgent assessment.
  • Get emergency help for trouble breathing, swelling of the tongue or throat, collapse, a seizure or inability to wake. Suspected overdose needs immediate poison-center or emergency advice; do not wait for symptoms.

What else should I know to stay safe?

  • Known QT prolongation, recent heart attack, uncompensated heart failure, ziprasidone allergy and certain heart-rhythm drug combinations rule out use. MAOIs are prohibited: allow at least 14 days after a psychiatric MAOI before ziprasidone and three days after ziprasidone before that MAOI. Linezolid and intravenous methylene blue need specific management.
  • Monitor weight, blood pressure, glucose, blood fats and movements; ECG, potassium, magnesium or blood-cell tests depend on risk. Review seizures, swallowing problems, kidney or liver disease and dehydration. Avoid alcohol and unreviewed sedatives, driving while impaired and overheating.
  • The short-acting injection is for professional intramuscular use, never intravenous use; kidney impairment needs additional consideration. Plan stopping or switching with the prescriber. Discuss pregnancy and breastfeeding because late-pregnancy exposure can affect newborn movement, feeding or breathing.

Urgent help and crisis support · Emergency & Crisis Resources (US)

What can help day to day?

  • Food makes a substantial difference to absorption. A dose taken without food may not give the same exposure as the prescribed dose taken with food.
  • The injection is short acting, not a depot or monthly treatment. Oral and injection instructions cannot be swapped.
  • A heart-rhythm interaction can matter even when the other medicine treats an unrelated problem, such as an infection.

How does it work?

Ziprasidone changes how brain cells respond to dopamine and serotonin, two chemical messengers. It blocks selected receptors, the proteins that receive those messages, and also has other effects on communication between cells. Researchers understand these actions more clearly than the full sequence by which they lead to improvement in symptoms.

Explore medication science

How was this medicine developed?

The FDA approved Geodon capsules in 2001; a separate short-acting injection followed in 2002. The two forms serve different treatment needs, and heart-rhythm precautions remain central to their use.

How do I say the name?

Ziprasidone: zi-PRAY-si-done. Capital letters show the stressed syllable.

Medicine forms and official information

Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.

Sources and References

Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.

  1. Geodon: current capsule and intramuscular prescribing information
  2. Geodon capsules: FDA approval history
  3. Ziprasidone: patient medicine information
  4. Geodon IM: FDA approval history
  5. Geodon: FDA capsule and injection label
  6. Geodon: Package Insert / Prescribing Information / MOA
  7. Ziprasidone injection: patient information
  8. Vraylar: current cariprazine prescribing information
  9. Ziprasidone: verified neutral parent, PubChem CID 60854
  10. NIMH: Understanding psychosis
  11. A qualitative investigation into the effects of akathisia - Health Research Authority
  12. Extrapyramidal side effects- Management
  13. Anxiety and panic attacks - NHS
  14. Agitation: MedlinePlus Medical Encyclopedia
  15. Frequently Asked Questions about Labeling for Prescription Medicines | FDA
  16. Serotonin syndrome: MedlinePlus Medical Encyclopedia
  17. Monitoring a person during and after antidepressant switching – NHS SPS - Specialist Pharmacy Service – The first stop for professional medicines advice

Giving medicine safely to children: family guide (PDF, 3 pages)

How information is checked

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top